Last updated: 10 May 2024 at 5:00pm EST

Richard Scott Struthers Net Worth




The estimated Net Worth of Richard Scott Struthers is at least 26.1 百万$ dollars as of 8 May 2024. Richard Struthers owns over 107,448 units of Crinetics Pharmaceuticals Inc stock worth over 18,516,700$ and over the last 6 years Richard sold CRNX stock worth over 7,582,778$.

Richard Struthers CRNX stock SEC Form 4 insiders trading

Richard has made over 15 trades of the Crinetics Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Richard exercised 107,448 units of CRNX stock worth 997,117$ on 8 May 2024.

The largest trade Richard's ever made was exercising 200,000 units of Crinetics Pharmaceuticals Inc stock on 2 November 2023 worth over 1,856,000$. On average, Richard trades about 31,180 units every 70 days since 2019. As of 8 May 2024 Richard still owns at least 364,933 units of Crinetics Pharmaceuticals Inc stock.

You can see the complete history of Richard Struthers stock trades at the bottom of the page.



What's Richard Struthers's mailing address?

Richard's mailing address filed with the SEC is C/O CRINETICS PHARMACEUTICALS, INC., 6055 LUSK BOULEVARD, SAN DIEGO, CA, 92121.

Insiders trading at Crinetics Pharmaceuticals Inc

Over the last 6 years, insiders at Crinetics Pharmaceuticals Inc have traded over 52,514,606$ worth of Crinetics Pharmaceuticals Inc stock and bought 3,613,259 units worth 62,800,483$ . The most active insiders traders include Advisors Llcperceptive Life...Jack NielsenCapital Viii, Llc Vivo Capi.... On average, Crinetics Pharmaceuticals Inc executives and independent directors trade stock every 20 days with the average trade being worth of 3,116,248$. The most recent stock trade was executed by Stephen F. Betz on 26 August 2024, trading 3,000 units of CRNX stock currently worth 159,570$.



What does Crinetics Pharmaceuticals Inc do?

neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.



Complete history of Richard Struthers stock trades at Crinetics Pharmaceuticals Inc

インサイダー
取引
取引
合計金額
Richard Scott Struthers
社長、CEO
オプション行使 997,117$
8 May 2024
Richard Scott Struthers
社長、CEO
オプション行使 38,200$
15 Apr 2024
Richard Scott Struthers
社長、CEO
オプション行使 380,025$
4 Apr 2024
Richard Scott Struthers
社長、CEO
オプション行使 95,500$
9 Nov 2023
Richard Scott Struthers
社長、CEO
オプション行使 1,856,000$
2 Nov 2023
Richard Scott Struthers
社長、CEO
オプション行使 19,100$
14 Aug 2023
Richard Scott Struthers
社長、CEO
販売 1,010,500$
11 Jul 2023
Richard Scott Struthers
社長、CEO
販売 1,040,500$
16 Jun 2023
Richard Scott Struthers
社長、CEO
オプション行使 21,201$
12 Oct 2022
Richard Scott Struthers
社長、CEO
販売 3,719,792$
13 Apr 2022
Richard Scott Struthers
社長、CEO
販売 541,186$
5 Apr 2022
Richard Scott Struthers
社長、CEO
販売 750,000$
7 Sep 2021
Richard Scott Struthers
社長、CEO
購入する 65,000$
2 Dec 2020
Richard Scott Struthers
社長、CEO
販売 520,800$
15 Jul 2020
Richard Scott Struthers
社長、CEO
オプション行使 19,100$
5 Aug 2019


Crinetics Pharmaceuticals Inc executives and stock owners

Crinetics Pharmaceuticals Inc executives and other stock owners filed with the SEC include: